NCT02823041

Brief Summary

This is a confirmatory randomized controlled trial of the efficacy of a novel intervention combining neuroplasticity-based cognitive training with aerobic exercise, compared to the same systematic cognitive training alone. Treatment occurs for 6 months after randomization, with a followup assessment at 12 months. The investigators hypothesize that combining neuroplasticity-based computerized cognitive training and neurotrophin-enhancing physical exercise will produce neurotrophin increases and cognitive and functional improvements, even relative to cognitive training alone. The investigators target the period shortly after a first episode of schizophrenia to maximize the generalization of cognitive improvement to functional outcome, before chronic disability is established.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable schizophrenia

Timeline
Completed

Started Oct 2016

Longer than P75 for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 6, 2016

Completed
3 months until next milestone

Study Start

First participant enrolled

October 13, 2016

Completed
6.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

November 27, 2023

Status Verified

November 1, 2023

Enrollment Period

6.7 years

First QC Date

June 29, 2016

Last Update Submit

November 24, 2023

Conditions

Keywords

cognitive trainingaerobic exerciseneurotrophic factorsrandomized controlled trialfunctional outcome

Outcome Measures

Primary Outcomes (3)

  • Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB) overall composite score

    The Overall Composite score from the MCCB is a summary of cognitive performance across seven domains.

    6 months

  • Global Functioning Scale: mean of Role and Social ratings

    A 10-point rating scale to evaluate role and social functioning

    6 months

  • Brain-derived neurotrophic factor (BDNF)

    BDNF is a key neurochemical factor known to mediate the effects of exercise in the brain

    6 months

Secondary Outcomes (3)

  • YMCA fitness test

    6 months

  • VO2 Max

    6 months

  • Role Functioning Scale

    6 months

Study Arms (2)

Cognitive Training & Exercise

EXPERIMENTAL

This arm involves a combination of systematic computerized cognitive training plus 150 minutes per week of aerobic exercise. All participants will also receive individual case management and supportive psychotherapy as well as Individual Placement and Support.

Behavioral: Cognitive TrainingBehavioral: Aerobic ExerciseBehavioral: Case management and supportive psychotherapyBehavioral: Individual Placement and Support

Cognitive Training

ACTIVE COMPARATOR

This arm includes the same systematic computerized cognitive training as the experimental condition, but without the additional aerobic exercise. All participants will also receive individual case management and supportive psychotherapy as well as and Individual Placement and Support.

Behavioral: Cognitive TrainingBehavioral: Case management and supportive psychotherapyBehavioral: Individual Placement and Support

Interventions

24 weeks of systematic computerized cognitive training, 4 hours per week. The first 12 weeks involves neurocognitive training, using auditory training exercises from Posit Science Brain HQ. The 2nd 12 weeks involves social cognitive training, using the Posit Science SocialVille modules. A weekly one-hour Bridging Skills Group is designed to aid generalization of training to everyday life situations.

Also known as: cognitive remediation
Cognitive TrainingCognitive Training & Exercise

Aerobic exercise occurs as two 45-minute sessions at the clinic and two 30-minute sessions at home weekly. Exercise involves an adaptation of interval training, including a variety of calisthenics that can be done without specialized equipment. Intensity of aerobic exercise is tailored to maintain an individualized target heart rate zone and is monitored by a heart rate recorder.

Also known as: physical exercise
Cognitive Training & Exercise

An individual therapist will provide weekly case management and therapy targeting the individual psychological problems and everyday functioning needs of the patient

Cognitive TrainingCognitive Training & Exercise

An job/school specialist will use the Individual Placement and Support model to help participants return to school or work and provide ongoing outreach support.

Also known as: supported education/employment
Cognitive TrainingCognitive Training & Exercise

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • a first episode of a psychotic illness that began within the past two years;
  • a diagnosis by DSM-5 of schizophrenia, schizoaffective disorder, mainly depressed type, or schizophreniform disorder;
  • sufficient acculturation and fluency in the English language to avoid invalidating research measures; and
  • residence likely to be within commuting distance of the UCLA Aftercare Research Program.

You may not qualify if:

  • inability to participate in aerobic exercise;
  • evidence of a known neurological disorder (e.g., epilepsy) or significant head injury;
  • evidence of moderate or severe alcohol or substance use disorder within the six months prior to the first episode or evidence that substance abuse triggered the psychotic episode or makes the schizophrenia diagnosis ambiguous; or
  • mental retardation, i.e. estimated premorbid IQ less than 70.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Los Angeles

Los Angeles, California, 90095-6968, United States

Location

Related Links

MeSH Terms

Conditions

SchizophreniaPsychotic Disorders

Interventions

Cognitive TrainingCognitive RemediationExerciseCase ManagementPalliative CareEmployment

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Neurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaPatient Care PlanningComprehensive Health CarePatient Care ManagementHealth Services AdministrationSocioeconomic FactorsPopulation Characteristics

Study Officials

  • Keith Nuechterlein, Ph.D.

    UCLA Department of Psychiatry & Biobehavioral Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 29, 2016

First Posted

July 6, 2016

Study Start

October 13, 2016

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

November 27, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will share

After primary results have been published, de-identified data for primary outcome variables will be available for sharing.

Locations